drugset / Trial / NCT06241638
Improving HbA1c Levels by Methylcobalamin Vitamin in Diabetic Volunteers
RandomizedParallel-groupSingle-blindBasic science
Summary
The current study was conducted to evaluate the prognostic implications of vitamin B12 admission on BMI and HbA1c levels in type 2 diabetic patients treated with Dapagliflozin as a routine medication.
Timeline
- Start
- 2022-07-01
- Primary completion
- 2023-06-30
- Completion
- 2023-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | methylcobalamin | Small molecule | 500 ug | Oral |
| Background | Dapagliflozin | Small molecule | 10 mg | Oral |